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Abstract	  
Nonalcoholic fatty liver disease (NAFLD) is associated with metabolic syndromes 15	  
spanning a wide spectrum of diseases, from simple steatosis to the more complex 
nonalcoholic steatohepatitis. To identify the deregulation that occurs in metabolic 
processes at the molecular level that give rise to these various NAFLD phenotypes, 
algorithms such as pathway enrichment analysis (PEA) can be used. These analyses 
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require the use of predefined pathway maps, which are composed of reactions 20	  
describing metabolic processes/subsystems. Unfortunately, the annotation of the 
metabolic subsystems can differ depending on the pathway database used, making 
these approaches subject to biases associated with different pathway annotations, and 
these methods cannot capture the balancing of cofactors and byproducts through the 
complex nature and interactions of genome-scale metabolic networks (GEMs). Here, 25	  
we introduce a framework entitled Minimum Network Enrichment Analysis 
(MiNEA) that is applied to GEMs to generate all possible alternative minimal 
networks (MiNs), which are possible and feasible networks composed of all the 
reactions pertaining to various metabolic subsystems that can synthesize a target 
metabolite. We applied MiNEA to investigate deregulated MiNs and to identify key 30	  
regulators in different NAFLD phenotypes, such as a fatty liver and liver 
inflammation, in both humans and mice by integrating condition-specific 
transcriptomics data from liver samples. We identified key deregulations in the 
synthesis of cholesteryl esters, cholesterol, and hexadecanoate in both humans and 
mice, and we found that key regulators of the hydrogen peroxide synthesis network 35	  
were regulated differently in humans and mice. We further identified which MiNs 
demonstrate the general and specific characteristics of the different NAFLD 
phenotypes. MiNEA is applicable to any GEM and to any desired target metabolite, 
making MiNEA flexible enough to study condition-specific metabolism for any given 
disease or organism.  40	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Author	  Summary	  
This work aims to introduce a network-based enrichment analysis using metabolic 
networks and transcriptomics data. Previous pathways/subsystems enrichment 
methods use predefined gene annotations of metabolic processes and gene annotations 
can differ based on different resources and can produce bias in pathways definitions. 45	  
Thus, we introduce a framework, Minimum Network Enrichment Analysis (MiNEA), 
which first finds all possible minimal-size networks for a given metabolic 
process/task and then identifies deregulated minimal networks using deregulated 
genes between two conditions. MiNEA also identifies the deregulation in key 
reactions that are overlapped across all possible minimal-size networks.  We applied 50	  
MiNEA to identify deregulated metabolic tasks and their synthesis networks in the 
steatosis and nonalcoholic steatohepatitis (NASH) disease using a metabolic network 
and transcriptomics data of mouse and human liver samples. We identified key 
regulators of NASH form the synthesis networks of hydrogen peroxide and ceramide 
in both humans and mice. We also identified opposite deregulation in NASH for the 55	  
phosphatidylserine synthesis network between humans and mice. MiNEA finds 
synthesis networks for a given target metabolite and due to this it is flexible to study 
deregulation in different phenotypes.  MiNEA can be widely applicable for studying 
context-specific metabolism for any organism because the metabolic networks and 
context-specific gene expression data are now available for many organisms.     60	  
Introduction	  	  
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of liver disease 
in western countries [1], affecting an estimated 25% to 45% of the general US 
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population, though this percentage is much higher among individuals suffering from 
obesity and diabetes [1, 2]. There are two categories of NAFLD: steatosis, which is an 65	  
accumulation of fat in the liver, and nonalcoholic steatohepatitis (NASH), which 
consists of the additional presence of liver inflammation and hepatocellular injury 
with or without fibrosis [2].  
Gene deregulation occurs when the cell no longer maintains precise control over 
certain genes, and therefore expressed proteins, and is associated with various 70	  
diseases such as NAFLD. Determining which genes are deregulated in disease and 
how these genes are deregulated can increase the understanding of any disease as well 
as provide new pathways for therapeutic treatments. To study gene deregulation, 
pathway enrichment analysis (PEA) uses maps of metabolic processes and subsystem 
reactions to determine if a given list of genes (gene set) is associated with a certain 75	  
biochemical pathway, shedding important conceptual insight into gene deregulation. 
Many PEA algorithms, such as ConsensusPathDB [3] and Piano [3, 4], have been 
developed to identify biological processes based on gene sets, while other algorithms, 
such as IMPaLA [5], are based on both gene and metabolite sets. While these 
algorithms can successfully provide insights about various disease phenotypes, they 80	  
use predefined metabolic maps that are limited to our current knowledge of these 
hugely intricate pathways and can differ depending on the pathway database used, 
meaning they could miss information about the wide range of complex metabolic 
interactions. These approaches are also subject to biases associated with the different 
pathway annotations, and they cannot capture the balancing of cofactors and 85	  
byproducts through the complex nature and interactions of genome-scale metabolic 
networks (GEMs). 
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To overcome this, a method has been developed based on elementary flux modes 
(EFMs), which are non-decomposable flux distributions in metabolic networks 
[6].These flux distributions indicate a conceptual description of metabolic pathways. 90	  
This method computes EFMs from a given GEM and uses tissue-specific 
transcriptomics to identify a subset of tissue-specific EFMs. However, the 
enumeration of all EFMs in a GEM can be computationally intractable, and EFMs are 
not necessarily specific to a target metabolite synthesis, meaning that targeted 
pathways are not always able to elucidated using EFMs.  95	  
One could also use graph-based methods (GBM) that require network topologies and 
gene expression profiles as inputs to extract deregulated subnetworks that occur 
between two conditions [7-9]. These methods have been applied to protein-protein 
networks for prostate cancer study, and they are potentially applicable to metabolic 
networks. GBM methods use graph-theoretic properties on network topologies but 100	  
miss information about additional constraints, such as mass balance [10] and 
thermodynamics [11]. Ideally, the results for these studies would include a set of mass 
balanced subnetworks that could be used to understand the carbon, energy, and redox 
flows from precursor metabolites to target metabolites and complex metabolic tasks. Here,	  we	  propose	  a	  method	  called	  Minimal	  Network	  Enrichment	  Analysis	  105	   (MiNEA)	  that	  compares	  two	  conditions	  using	  transcriptomics,	  proteomics,	  and	  metabolomics	  to	  identify	  deregulated	  minimal	  networks	  (MiNs),	  which	  are	  reactions	  pertaining	  to	  various	  metabolic	  subsystems	  that	  can	  synthesize	  a	  target	  metabolite.	  The	  MiNEA	  algorithm	  works	  by	  formulating	  metabolic	  tasks	  (MTs)	  to	  mimic	  the	  various	  NAFLD	  phenotypes,	  such	  as	  lipid	  droplet	  formation,	  110	   lipoapoptosis,	  liver	  inflammation,	  and	  oxidative	  stress.	  These	  MTs	  include	  the	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  known	  set	  of	  metabolites	  necessary	  to	  form	  the	  modeled	  phenotype.	  The	  cell	  can	  use	  different	  pathways	  to	  form	  the	  same	  metabolites	  and	  create	  the	  same	  phenotypes,	  and	  the	  purpose	  of	  MiNEA	  is	  to	  identify	  deregulated	  alternative	  routes	  for	  a	  given	  MT	  between	  two	  conditions,	  such	  as	  a	  control	  and	  treatment.	  115	   First,	  MiNEA	  uses	  these	  MTs	  to	  compute	  alternative	  thermodynamically	  feasible	  MiNs	  applying	  thermodynamic	  constraints	  [11,	  12]	  to	  a	  mouse	  GEM	  [13].	  Then,	  it	  uses	  mouse	  and	  human	  liver	  sample	  expression	  data	  [1,	  14]	  and	  identifies	  deregulated	  metabolic	  processes	  in	  mice	  and	  humans	  that	  potentially	  lead	  to	  the	  NAFLD	  phenotypes. 120	  
MiNEA identified an upregulation in the oxidative stress synthesis network in mice, 
but this network was found to be downregulated in humans. The cholesterol and 
triacylglycerol synthesis networks were deregulated in humans only, while the 
ceramide synthesis network was only deregulated in mice. We found downregulated 
reactions in the synthesis network for cholesteryl esters, cholesterol, and alanine in 125	  
both humans and mice. We further identified downregulated reactions in the 
superoxide anion (SOA) synthesis network in humans, specifically in NASH as 
opposed to steatosis, while upregulation was found in the SOA synthesis network in 
mice. This perturbation through the SOA synthesis network in NASH suggested an 
unbalanced ceramide synthesis, and studies have shown that the ceramide is a key 130	  
regulator of apoptosis and promotes fibrosis in the hepatic steatosis model [15, 16].  
MiNEA can generate MiNs for any target metabolite, e.g. a metabolite produced 
under specific phenotypes or a biomass building block [17] that is needed for cell 
growth. Additionally, MiNEA can integrate condition- and context-specific omics 
data to understand the deregulated phenotypes associated with a set of differentially 135	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expressed genes. These characteristics make MiNEA a versatile tool for exploring and 
understanding different metabolic phenotypes. 
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Results	  and	  Discussions	  
Experimental	  details	  for	  MiNEA	  
Nonalcoholic fatty liver disease (NAFLD) has been defined as a metabolic disease 140	  
associated with insulin-resistance syndrome [18]. To study the differences seen in 
NAFLD phenotypes between mouse and human manifestations, we collected human 
expression data from the three diagnosis groups, normal (N), steatosis (S), and 
nonalcoholic steatohepatitis (NS), and mouse expression data from control and DDC-
supplemented diet conditions for three genetically different mouse strains, AJ, B6, 145	  
and PWD. DDC-supplemented diet reproduces steatosis and NASH phenotypes (see 
Materials and Methods for detail). We refer to these data as human expression data 
and mouse expression data throughout this section and integrate it into a mouse model 
iMM1415 that is constructed based on a human GEM Recon1 [13]. We analyzed both 
human and mouse MTs using iMM1415 with the assumption that both types of 150	  
mammalian cells have a similar metabolism (See S1 text). In the following sections, 
we analyzed the deregulation of minimal networks in core reactions and enriched 
minimal networks based on the deregulation (up- or downregulated) genes.  	  Minimal	  networks	  	  155	  
GEMs represent an entire cellular metabolic network in the form of mathematical 
constraints [19]. These network reconstructions have grown rapidly in the last 
decades, and now many GEMs for different organisms are available [20]. GEMs and 
condition-specific experimental data can be employed to generate and test hypotheses 
using the Minimal Network Enrichment analysis (MiNEA) framework that has been 160	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developed in this study. As compared to a method the had been proposed for finding 
subnetworks from a GEM that optimizes only some part of metabolic networks to find 
subnetworks [21], MiNEA optimizes whole metabolic networks to find minimal 
networks.	  
To examine the data that can be derived from MiNEA in terms of NAFLD, we first 165	  
wanted to compute MiNs for each of the MTs in Table 7 (see Materials and Methods 
for the table) that were significant phenotypes in NAFLD. Instead of representing a 
main linear route between precursors and targets of MTs, a MiN is instead composed 
of many subsystems integrated into subnetworks that must be active, meaning 
reactions of subnetworks carries fluxes, to fulfill the target MT. The MiNEA 170	  
algorithm facilitates enumeration of alternative MiNs and provides more flexibility to 
the analysis of different metabolic phenotypes and their respective environmental and 
genetic perturbations. The use of MT for analysis with MiNEA allows this method to 
be more easily generalized and applied to the study of other metabolic phenotypes and 
diseases.  175	  
A summary of the MiNs calculated for the MTs in Table 7 (see Materials and 
Methods for the table) are shown in Table 1. The shortest MiNs were for the synthesis 
of hydrogen peroxide (H2O2) (network size = 37), and the longest were for the 
synthesis of cholesteryl ester (network size = 131; Table 1). We found the greatest 
number of possible alternatives for the hexadecanoate (HDCA) synthesis and the least 180	  
number possible for the phosphatidylserine (PS) synthesis (Table 1), suggesting that 
the HDCA synthesis is more flexible and the PS synthesis less flexible towards 
alternative formation compared to the rest of the MTs. Reactions that overlapped 
between all alternative MiNs were called high-frequency reactions (HFRs), and the 
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percentage of HFRs shows how similar or divergent a MiN is compared to the other 185	  
MiNs. The percentage of HFRs was between 62% to 91% across the MTs (Table 1). 
In the superoxide anion (SOA) and the hydrogen peroxide (H2O2) synthesis, 62% and 
89% of the reactions were HFRs, respectively, which suggests that the alternative 
MiNs for a SOA synthesis were more divergent compared to a H2O2 synthesis.  
Table 1. Summary of MiNs found for the target metabolites comprising the various NAFLD 190	  
phenotypes. Synthesis of a target metabolite represents a MT. For each MT, we enumerated alternative 
MiNs. The number of reactions in each MiN represents the size of the MiN. “# Alt” and “# MT HFRs” 
represent the number of alternatives and the number of overlapping reactions between all alternatives 
of a given MT, respectively. The symbol “#Phenotypic HFRs” represents the number of overlapping 
reactions form all alternatives of a set of MTs that are associated with a given phenotype.  195	  
 
As an expanded example, a MiN from the H2O2 synthesis comprises many reactions 
from various metabolic subsystems (Fig. 1). Each MiN represents a group of active 
reactions, which are reactions that carries fluxes, within multiple metabolic 
subsystems/pathways that are required for a MT, while a pathway is a group of 200	  
annotated reactions. In the example in Figure 1, most of the active reactions for the 
H2O2 synthesis are from the pentose phosphate pathway (PPP) and the 
glycolysis/gluconeogenesis pathway. PEA differs in that it identifies a marked 
Phenotypes Metabolic Short Min2Size #2Alt #2MT 2%2MT #2Phenotypic
Tasks2(MTs) Name #2rxns 2HFRs2 2HFRs HFRs
Oxidative)Stress Hydrogen)peroxide H2O2 37 126 33 89 16
Superoxide)anion SOA 42 144 26 62
Apoptosis)and Alanine ALA 98 39 84 86 36
Inflammation Ceramide CRM 115 8 105 91
Glutamine GLU 116 34 83 72
Lipid)droplet Cholesterol CHOL 121 60 108 89 27
Cholesteryl)ester CHOL_ES 131 237 112 85
Diacylglycerol DAG 82 232 67 82
Hexadecanoate HDCA 75 266 61 81
Phosphatidic)acid PA 83 245 65 78
Phosphatidylinositol PAIL 94 237 68 72
Phosphatidylethanolamine PE 128 7 103 80
Phosphatidylserine PS 125 6 98 78
Triacylglycerol TAG 84 257 62 74
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deregulation in a pathway as compared to MiNEA, which identifies deregulation in a 
MiN that could include multiple pathways.  205	  
 
 
Figure 1. A minimal network (MiN) and high-frequency reactions (HFRs). A MiN 
of H2O2 synthesis is illustrated. Each box represents a different metabolic 
subsystem/pathway. The number of total reactions listed in each box represents the 210	  
annotated reactions for that subsystem. Active reactions carry non-zero flux, and the 
number of these present in each subsystem is shown in green text. 
 
Other
# total reactions = 525
# active reactions = 9
Glycolysis/Gluconeogenesis
# total reactions = 29
# active reactions = 10
Pentose Phosphate Pathway
# total reactions = 18
# active reactions = 8
Pyruvate Metabolism
# total reactions = 27
# active reactions = 1
Tyrosine metabolism
# total reactions = 45
# active reactions = 1
# total reactions = 706
# active reactions = 8
Transport
H202 synthesis
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We further analyzed the HFRs within each phenotype and found that the most 
represented metabolic pathway in the apoptosis and inflammation (AI) phenotype was 215	  
related to amino acid metabolism (# phenotypic HFRs=36; Table 1; Fig. 2). 
Interestingly, while the lipid droplet (LD) phenotype has many associated MTs, it 
shares 27 reactions in which 5 reactions are from the glycolysis/gluconeogenesis 
pathway (Fig. 2). These shared reactions can be constitutive candidates for the LD 
phenotypes. The HFRs forming the subsystems in Figure 2 are potential candidates 220	  
for the key regulators of the NAFLD phenotypes.  
 
Nucleotides+Other
Glycolysis/Gluconeogenesis
Oxidative Phosphorylation
Fatty Acid Activation
Urea cycle
# total reactions = 706
# active reactions = 20
# HFR = 5
Transport
Lipid droplet
# total reactions = 29
# active reactions = 11
# HFR = 5
# total reactions = 5
# active reactions = 4
# HFR = 4
# total reactions = 25
# active reactions = 4
# HFR = 4
# total reactions = 37
# active reactions = 3
# HFR = 1
Citrate Acid Cycle
# total reactions = 17
# active reactions = 12
# HFR = 1
# total reactions = 677
# active reactions = 26
# HFR = 7
Other
Glycolysis/Gluconeogenesis
Pentose Phosphate Pathway
# total reactions = 516
# active reactions = 3
# HFR = 2
Extarcellular Transport
Oxidative stress
# total reactions = 29
# active reactions = 11
# HFR = 2
# total reactions = 18
# active reactions = 8
# HFR = 8
# total reactions = 513
# active reactions = 10
# HFR = 4
Other
Amino Acid Metabolism
Folate Metabolism
Tetrahydrobiopterin
# total reactions = 706
# active reactions = 20
# HFR = 5
Transport
Apoptosis and 
inflammation
# total reactions = 129
# active reactions = 34
# HFR = 19
# total reactions = 50
# active reactions = 3
# HFR = 3
# total reactions = 9
# active reactions = 2
# HFR = 2
Citrate Acid Cycle
# total reactions = 17
# active reactions = 9
# HFR = 1
# total reactions = 513
# active reactions = 21
# HFR = 6
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Figure 2. HFRs for all the phenotypes. The number of HFRs in the various 
pathways is shown for the oxidative stress, apoptosis and inflammation, and lipid 
droplets phenotypes. See Figure 1 caption for a detailed explanation of the chart.  225	  
 Deregulation	  in	  HFRs	  
The HFRs within each MT create a topology of reaction hubs in metabolic networks 
that can be similar to protein hubs in protein-protein interaction networks [22, 23], 
and the misregulation of these hubs in disease can explain the origin of disease 230	  
phenotypes. Therefore, we performed an analysis of HFR deregulation to study the 
NAFLD-specific phenotypes. We identified the up- and downregulated reactions from 
mouse and human expression data (described in S1) and analyzed the HFRs for which 
the associated genes were found to be deregulated. In humans, the number of 
downregulated HFRs was higher compared to upregulated HFRs for the NS vs N and 235	  
NS vs S across all phenotypes (Table 2). In mice, however, the NS vs N, NS vs S, and 
S vs N comparisons showed a higher number of upregulated HFRs compared to 
downregulated ones for the oxidative stress (OS) phenotype, but for the LD and AI 
phenotypes, we observed similar patterns of up- and downregulated HFRs to humans 
(Table 2).	  240	  
	  
Table 2. The deregulated HFRs across all comparisons. Numbers in the table indicate the number of 
up- and downregulated HFRs. In mice, N represents the control diet (N≈AJ, N≈PWD, or N≈B6 strain 
fed the control diet). Under the DDC-supplemented diet, AJ mice tended towards NASH phenotypes 
and PWD mice tended towards steatosis phenotypes. Thus, in mice, the symbols NS stand for AJ and S 245	  
All rights reserved. No reuse allowed without permission. 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/402222doi: bioRxiv preprint first posted online Aug. 28, 2018; 
	   14	  
stand for the PWD, all with DDC-supplemented diet (NS≈AJ with DDC-supplemented diet; S≈PWD 
DDC-supplemented diet). 
 
 
 250	  
We further analyzed the deregulation in reaction hubs for each MT to identify the 
most perturbed MTs in NS and S and the differences between NS and S. In humans, 
the percentage of downregulated HFRs was higher than upregulated ones for the 
synthesis of all metabolites in the NS vs N and NS vs S states, while the percentage of 
upregulated HFRs was higher than downregulated ones for the S vs N state (Fig. 3). 255	  
There was a higher percentage of downregulated HFRs for the cholesterol (CHOL) 
and cholesteryl ester (CHOL_ES) synthesis networks in NS vs S and for the 
superoxide anion (SOA) and H2O2 synthesis networks in NS vs S (Fig. 3). This means 
that downregulated HFRs have a higher impact on NASH phenotypes.  
 260	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Since the mouse strains AJ and PWD show phenotype specific to NS and S, 
respectively, and the mouse strain B6 show low S and NS phenotypes after feeding 
with the DDC diet (Materials and Methods) and thus we analyzed B6 separately.  For 
mice, in NS vs N (the comparison associated to AJ) and B6 DDC vs N comparisons, 
we found that the percentage of downregulated HFRs in the SOA and H2O2 synthesis 265	  
networks was higher than for upregulated ones (Fig. 3). This indicates synthesis 
networks of oxidative stress were found to be perturbed for AJ and B6 mice.  
Additionally, for the NS vs S in mice, an elevated percentage of upregulated HFRs 
was identified for the synthesis of the triacylglycerol (TAG), phosphatidylinositol 
(PAIL), diacylglycerol (DAG), and phosphatidic acid (PA) metabolites, and a high 270	  
percentage of downregulated HFRs was found for the alanine (ALA) and glutamine 
(GLU) synthesis networks (Fig. 3). This is consistent with the observation of lipid 
droplet perturbation in NASH and steatosis [24], and it further suggests that the 
synthesis of TAG, PAIL, DAG, and PA are important for lipid droplet formation. 
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 275	  
Figure 3. Quantification of up- and downregulated HFRs. Symbols ‘h’ and ‘m’ in 
comparison’s labels represent human and mouse, respectively, and ‘up’ and ‘down’ 
indicate up- and downregulation, respectively. See the legend of the Table 3 for the 
association of mouse strains to the symbols N, NS, and S. “B6 up” and “B6 down” 
represent the up- and downregulated HFRs for the B6 mouse strain comparing the 280	  
DDC vs control diet. We quantified the percentage of up- and downregulated HFR 
using a colored heat map.  
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For the synthesis of ROS, such as H2O2, the human NS vs N case presented with a 
high percentage of downregulated HFRs, while the same case in mice presented with 285	  
a high percentage of upregulated HFRs (Fig. 3). The reactions of the PPP associated 
with genes TKT1, TKT2, GND, and TALA were identified as downregulated HFRs 
in the NS vs N human. However, for the NS vs N mouse and B6 DDC vs N these 
reactions were identified as upregulated. PPP is known as a source of nicotinamide 
adenine dinucleotide phosphate (NADPH) that prevents oxidative stress. Thus, the 290	  
different patterns of regulation observed for these reactions can unbalance both 
NADPH concentration and H2O2 synthesis. Interestingly it has been reported that the 
unbalance in NADPH production through PPP by either an under or over-production 
of NADPH may induce oxidative stress [25, 26]. 
 295	  
The acetyl CoA C acetyltransferase (ACACT1rm) and phosphoglycerate mutase 
reactions of the ceramide synthesis networks were identified as downregulated HFRs 
for the NS vs S and NS vs N in humans along with the NS vs N in mice. Thus, 
perturbation in the genes associated with these reactions can affect the ceramide level 
in NASH in both mice and humans. In line with this finding, a study suggested that 300	  
deregulated ceramide production promotes liver injury and the development of NASH 
through disruption of endoplasmic calcium homeostasis, as well as through the 
inhibition of autophagy [27].  
 Enriched	  MTs	  in	  human	  and	  mouse	  based	  on	  deregulated	  genes	  305	  
We want to identify deregulation at network level based on an enrichment analysis 
with deregulated enzymes or genes.  A Minimal network (MiN) of a metabolic task 
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(MT) contains metabolites, active reactions and their associated enzymes in order to 
fulfill the MT. To identify deregulated MTs and their associated MiNs (see Materials 
and Methods section for definitions) in steatosis and NASH, we performed Minimal 310	  
Network Enrichment Analysis (MiNEA) (see Materials and Methods section) using 
mouse and human expression data. We identified deregulated genes (S1 text; Table 
S1-S3), and for each set of deregulated genes, we estimated the p value.  
 
Applying MiNEA to the NS vs N human case, we identified deregulated MiNs which 315	  
corresponded to the synthesis of H2O2, PA, and TAG (Table 3; Table S4 & S5). We 
computed the percentage of significantly enriched MiNs from all generated 
alternatives of each MT and scored the deregulated MiNs using the Alternative 
Minimal Network Frequency (AMiNF), which represents the percent of MiNs with 
enrichment in deregulated genes. For the NS vs N case in humans, H2O2 synthesis had 320	  
the highest AMiNF (AMiNF = 0.143) compared to all other deregulated MTs (Table 
3), suggesting that the deregulation of H2O2 metabolism and oxidative stress 
contributes to NASH. Indeed, a study has shown that a marked alteration of H2O2 
concentration can lead to different types of oxidative stress [25].  
 325	  
Table 3. The significantly deregulated MTs across all comparisons based on deregulated genes. The 
numbers in the table indicate Alternative Minimal Network Frequency (AMiNF). The mouse strains 
associated with N, NS, and S are described in the legend of Table 2. For the calculation of AMiNF 
p < 0.05 was considered statistically significant.  
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 330	  
 
When we applied MiNEA to NS vs S in humans, we found the most deregulated 
MiNs to be associated with CHOL synthesis (AMiNF =	  0.7). Interestingly, TAG 
synthesis was also deregulated in NS vs N, suggesting that lipid droplet formation can 
be perturbed in the NASH state but through different components.  335	  
 
In mice, we did not observe marked deregulation in NS vs N and S vs N, but we 
observed significant deregulation in NS vs S for the synthesis of ALA, GLU, 
ceramide (CRM), PS, and phosphatidylethanolamine (PE) (Table 3), suggesting that 
these MTs are subject to different perturbations between the NASH and steatosis 340	  
states.  
 
In humans, MiNEA identified deregulation in the CHOL and TAG synthesis network, 
which are lipid droplet constituents. Similar deregulation was observed for the lipid 
droplet constituents in mice through the PS and PE synthesis networks. Thus, because 345	  
  N" NS" S" MT"
N" ! ! ! ! N"
"" !! !! 1! ALA!! ""
"" !! !! 1! GLU! ""
"" !! !! 1! CRM! ""
NS" !! !! 0.833! PS! NS"
"" !! !! 0.714! PE! ""
"" 0.143! !! !! H2O2! ""
"" 0.016! !! !! TAG! ""
"" 0.004! !! !! PA! ""
S" !! 0.7! !! CHOL! S"
N" NS" S"
Mouse!
Hu
m
an
!
Human!
M
ou
se
!
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MiNEA was applied with information on deregulated genes, we find that in both 
humans and mice, lipid droplet formation is perturbed but through different lipid 
constituents.  
 Enriched	  MTs	  in	  humans	  and	  mice	  based	  on	  up-­‐	  and	  downregulated	  reactions	  350	  
To identify whether a specific up- or downregulated MiN was associated with the 
NAFLD phenotypes, we performed MiNEA while enriching for up- and 
downregulated reactions separately (S1 Text). 
 
In humans, we identified upregulated MiNs for the synthesis of PS and PE in N vs S 355	  
(Table 4; Table S6 & S7). For the NS vs N and NS vs S cases, we identified 
downregulated MiNs associated with the synthesis of CHOL_ES, CHOL, ALA, and 
GLU (Table 5; Table S8 & S9), but none were found to be upregulated. This implies 
that in NASH the synthesis of cholesterol and the glucogenic amino acids alanine and 
glutamine are downregulated. Interestingly, in the NS vs N case, only 3% of the 360	  
cholesterol synthesis alternatives were significantly downregulated (Table 5). 
Although it is a relatively small frequency, it can provide important leads, such as 
deregulation in metabolic tasks and hypotheses that would have been missed by the 
commonly used pathway enrichment methods, such as [3, 5]. In general, these studies 
suggested that MiNEA can identify deregulated alternative MiNs under different 365	  
conditions. For example, previous pathway analysis methods [3, 5] lack an 
enumeration of alternatives that would have been failed to identify cholesterol 
synthesis as downregulated in NS vs N (Table 5).  
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Table 4. The significantly deregulated MTs across all comparisons based on upregulated reactions. For 370	  
a detailed understanding, see the legend of Table 2. Numbers of the table represents AMiNF and for the 
calculation of AMiNF p value < 0.005 was used.   
 
 
In mice, the MiNs associated with the synthesis of ALA, CRM, PE, PS, CHOL_ES, 375	  
and GLU were identified as downregulated in NS vs N (Table 5). Interestingly, in S vs 
N, only the GLU synthesis network was upregulated (Table 4). For the NS vs S case, 
we found major deregulations. Specifically, we found five upregulated networks (PA, 
TAG, DAG, PAIL, and PS) and five downregulated (ALA, GLU, CRM, PS, and PE) 
synthesis networks. Within the alternative MiNs that are used for the synthesis of PS, 380	  
we found some networks that were upregulated and some that were downregulated. 
Since there was a higher frequency of downregulated MiNs (AMiNF = 0.5) compared 
to upregulated ones (AMiNF = 0.167), we could hypothesize that the downregulation 
of PS synthesis is an important molecular mechanism specific to NASH. Here, if we 
use pathways enrichment methods [3, 5] then we cannot associate two different 385	  
AMiNF score for a given MT due to the lack of alternative enumeration and would 
have been failed to give a higher confidence to downregulation of PS synthesis.  
N" NS" S" MT"
N" !! !! 0.029! GLU! N"
" !! !! 1! PA! "
" !! !! 1! TAG! "
NS" !! !! 1! DAG! NS"
" !! !! 0.979! PAIL! "
" !! !! 0.167! PS! "
S" 0.429! !! !! PS! S"
" 0.167! !! !! PE! "
N" NS" S"
Mouse!
Hu
m
an
!
Human!
M
ou
se
!
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Table 5. The significantly deregulated MTs across all comparisons based on downregulated reactions. 
For detail understanding see the legend of Table 4. For the AMiNF calculation p < 0.005 was 390	  
considered statistically significant.   
 
 
The cholesterol, glutamine, and alanine syntheses were found to be similarly 
deregulated in humans and mice for the NS vs N case. In contrast, the PS synthesis 395	  
was differently deregulated between the two species (Table 4 and 5). Despite this 
opposite response in the regulation of the PS synthesis between humans and mice, it 
appears that the level of PS is perturbed in NASH. Overall this observation suggests 
that different regulations in gene expression can translate to different effects on the 
production of lipid droplet synthesis.  400	  
  N" NS" S" MT"
"" !! 1! !! ALA! ""
"" !! 1! !! CRM! ""
N" !! 0.857! !! PE! N"
" !! 0.833! !! PS! "
" !! 0.62! !! CHOL_ES! "
" !! 0.588! !! GLU! "
" 0.034! !! !! CHOL_ES! "
" !! !! 1! ALA! "
NS" !! !! 1! GLU! NS"
" !! !! 1! CRM! "
" !! !! 0.5! PS! "
" !! !! 0.429! PE! "
" !! 1! !! CHOL_ES! "
S" !! 1! !! CHOL! S"
!! !! 0.128! !! ALA! !!
!! !! 0.004! !! GLU! !!
N" NS" S"
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!
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Integration	  of	  metabolite	  concentration	  data	  into	  a	  thermodynamically	  feasible	  
metabolic	  model	  
The integration of metabolomics can change the size and structure of the MiNs for 
MTs by eliminating thermodynamically infeasible reaction directionalities. In mice, 405	  
there are available metabolic profiles for the N, NS, and B6 cases [1]. We integrated 
these profiles into the iMM1415 [11, 13] and found that, in this case, there are not 
marked changes in the MiNs and the result in the HFRs, which means we did not 
found a marked impact on the synthesis networks of NAFLD phenotypes. A further 
sensitivity analysis can guide future metabolomics studies to target metabolites that 410	  
have a marked thermodynamic impact on a metabolic network [28]. Thus, the 
information content of such metabolite sets can be influential and more relevant to the 
phenotypes under study.  
 
We applied MiNEA for the study of deregulated metabolic processes rather signaling 415	  
and regulatory processed because metabolism is better characterized, as is shown with 
the increased availability of GEMS for many organisms. Despite the challenges in 
reconstructing constraint-based signaling networks, recently such reconstructions 
have started to become available. Signaling networks for the toll-like receptor (TLR) 
and epidermal growth factor receptor (EGFR) are now available, and MiNEA can be 420	  
extended to include these networks [29, 30], meaning that MiNEA could easily be 
applied to the study of deregulation in signaling networks. 
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Materials	  and	  Methods	  	  
	  425	  
Microarray	  gene	  expression	  analysis	  of	  human	  liver	  samples
The microarray gene expression data pertaining to the three diagnostic groups (normal 
[N], Steatosis [S], and NASH [NS]) were collected from the ArrayExpress public 
repository for microarray data under the accession number E-MEXP-3291 [14]. We 
performed an analysis of the differentially expressed genes (DEGS) and a pairwise 430	  
comparison between diagnostic groups. To control the false discovery rate at level of 
0.05, multiple hypothesis testing was used [31]. 
 
Mice	  phenotypes	  after	  feeding	  a	  3,5-­‐diethoxycarbonyl-­‐1,4-­‐dihydrocollidine	  (DDC)-­‐
supplemented	  diet	  	  435	   	  
NASH phenotypes can be reproduced in mouse models by treatment of chronic 
intoxication of with 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC)-supplemented 
diet [1]. Three genetically different mouse strains AJ, B6, and PWD were fed with a 
DDC-supplemented diet. Under DDC-supplemented diet, the steatosis and NASH 440	  
phenotypes were the most obvious in the PWD and AJ strains, respectively, while for 
the B6 strain, low levels of the steatosis and NASH phenotypes were observed [1]. 
The B6 mouse strain showed less induction of the NASH phenotype than the AJ strain 
[1]. 
Association	  of	  mouse	  strains	  with	  human	  diagnoses	  groups	  	  445	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The normal (N) feeding group is associated with mice fed the control diet. All mice 
strains, AJ, B6 and PWD, were fed this diet and are labeled as N≈AJ, N≈PWD or 
N≈B6 to indicate the control diet and mouse strain. After feeding the DDC-
supplemented diet, AJ and PWD showed high NASH phenotypes and high steatosis 
phenotypes, respectively [1] . Thus, under the DDC-supplemented diet, the symbol 450	  
for steatosis (S) is associated with the PWD mouse strain and the symbol for NASH 
(NS) is associated the AJ mouse strain (with DDC-supplemented diet: NS≈AJ, 
S≈PWD). Thus, NS vs N represents the AJ mouse strain treated with the DDC diet vs 
the AJ mouse strain fed the control diet, S vs N represents the PWD mouse strain 
treated with the DDC diet vs the PWD mouse strain fed the control diet, and NS vs S 455	  
represents the AJ mouse strain treated with the DDC diet vs the PWD mouse strain 
fed the DDC diet.  	  
 
Metabolite	  concentration	  and	  RNA-­‐seq	  gene	  expression	  data	  from	  mouse	  liver	  
samples	  460	  
Metabolite concentration data and RNA-seq gene expression data from mouse liver 
samples of the three mouse strains (AJ, B6, and PWD) measured under the control 
and DDC-supplemented diet conditions were collected from the work of Pandey et al. 
[1]. The R-package “edgeR” [32] was used to identify the differentially expressed 
genes (DEGs) using three biological replicates of each mouse strain for both the 465	  
control and the DDC-treated conditions. Strain-wise identification of the DEGs 
between the DDC-treated and control states was performed separately for each mouse 
strain. We used the Benjamini-Hochberg procedure implemented in edgeR to control 
the false discovery rate to a level of 0.05 [31]. 	  470	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Formulation	  of	  metabolic	  tasks	  (MTs)	  based	  on	  steatosis	  and	  steatohepatitis	  
(NASH)	  phenotypes	  	  
Steatosis can occur due to the accumulation of lipid droplets in the liver, which can 
subsequently lead to NASH upon liver inflammation [33]. Lipid droplets are 
composed of many lipid metabolites [34, 35], which are summarized in Table 7. 475	  
Reactive oxygen species (ROS), such as the superoxide anion, can also damage 
hepatic membranes and play an important role in the development of NASH [36]. To 
study these various phenotypes and their role in the various forms of liver disease, the 
metabolites associated with their various phenotypes were examined. Table 7 
summarizes the key metabolites associated with the major liver disease phenotypes: 480	  
lipid droplets, liver inflammation, apoptosis, and oxidative stress. We investigate the 
synthesis networks of these metabolites using MiNEA, where we called the synthesis 
of a metabolite as a metabolic task (MT). 
 
Table 7: Metabolites associated with NAFLD phenotypes. This provides a summary of key metabolites 485	  
associated with the four phenotypes and their corresponding references. Metabolites are taken from the 
mouse metabolic model of Sigurdsson and colleagues [13].	  
Metabolites Phenotype Reference 
Diacylglycerol, phosphatidylethanolamine, cholesteryl esters, 
triacylglycerol, hexadecanoate, cholesterol, phosphatidic acid, 
phosphatidylinositol, phosphatidylserine 
Lipid droplets [34, 35, 37] 
Ceramide Inflammation [27, 37, 38] 
Alanine, glutamine, ceramide Apoptosis [39] 
Superoxide anion, hydrogen peroxide Oxidative stress [36] 
  
Minimal	  network	  enrichment	  analysis	  (MiNEA)	  algorithm	  	  The	  cell	  can	  use	  various	  different	  pathways	  depending	  on	  the	  current	  state	  and	  490	   conditions	  of	   the	  environment	   to	   fulfill	   its	   immediate	  metabolic	  needs. In order 
for MiNEA to identify deregulated alternative routes for a given MT between two 
conditions (Fig. 4), the inputs required are a metabolic model, a list of MTs, and gene 
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or protein expression data. In this work, we used a mouse GEM (iMM1415) 
reconstructed by Sigurdsson and colleagues [13], a list of MTs which are the synthesis 495	  
of the metabolites shown in Table 7, and gene expression data of mouse and human 
liver samples [1, 14]. 
 
The MiNEA calculations begin by applying thermodynamic constraints to the model 
as described previously [11] to eliminate thermodynamically infeasible reactions, 500	  
meaning that reactions from the metabolic network can carry fluxes only if 
thermodynamics allows [12] (Fig. 4; step 1). Then, it enumerates all the 
thermodynamically feasible minimal-size networks (MiNs) that are active for the 
given list of provided MTs (Fig. 4; step 2), and all of these MiNs are composed of 
reactions that carry non-zero flux. For this step, the following mixed-integer linear 505	  
programming (MILP) problem is applied with the objective of minimizing the number 
of reactions that carry flux or maximizing the number of reactions that cannot carry 
flux, while enforcing that the network should be able to synthesize the metabolites 
listed in Table 1: 
𝑀𝑎𝑥𝑖𝑚𝑖𝑧𝑒     𝑧!"#,!!!"#!!!         𝑆. 𝑣 = 0    0 ≤ 𝑣! ≤ 𝑣!"#,! ∗ 𝑍!"#,!    𝑣!" ≥ 𝑐 ∗ 𝑉!",!"# 
RGEM is the number of reactions in a GEM and 𝑧!"#,! is a binary variable associated 510	  
with reaction i. Reversible reactions were split into two forward reactions. 𝑉!",!"#  is 
the maximum yield to produce a metabolite associated with a MT. The parameter c is 
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generates MiNs that allow for flexibility on the yield from the MT. We chose c = 0.8 
to allow for a yield of at least 80% of the maximum yield for the associated MT.  
 515	  
All alternative MiNs that are the minimum size (msize) for the synthesis of the 
metabolites in Table 1 are enumerated as described by Figueiredo and colleagues [40] 
(Fig. 4; step 3). One can enumerate many alternative networks larger than msize, such 
as msize+1 and msize+2. Each MiN is a subnetwork comprising a set of reactions, 
metabolites, and reaction-associated genes through gene-protein-reaction (GPR) 520	  
association. In step 4, the deregulated genes and proteins that differ between the two 
conditions under study are identified (Fig. 4). Finally, a hypergeometric test is 
performed on the sets of deregulated genes or deregulated reactions to identify the 
deregulated MiNs (Fig. 4; Step 5).  
 525	  
Apply mass balance and thermodynamic constraints
Minimize number of reactions 
Find alternative minimal networks (MiNs) 
that comprises active reactions 
Identified deregulated genes, proteins, reactions, and 
metabolites between two conditions 
Hypergeometric 
test
Deregulated metabolic tasks and their alternative minimal networks (MiNs)
Deregulated high frequency reactions
Step 1
Step 2
Step 3
Step 4
Step 5
Metabolic model 
(e.g. iMM1415)
 
Omics data
(e.g. Transcriptomics, proteomics)
Metabolic tasks 
(e.g. synthesis of ceramide)
Input
Output
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Figure 4. Minimal network enrichment analysis (MiNEA) overview. For each 
metabolic task (MT), MiNEA computationally enumerates MiNs that comprise active 
reactions for the MT. The inputs required for the MiNEA analysis are a genome-scale 
metabolic network (GEM), a given list of metabolic tasks (MTs), and transcriptomics 
data. Using this, alternative minimal networks (MiNs) are enumerated for MTs using 530	  
a GEM. (steps 1–3). Transcriptomics data are used to identify differentially regulated 
genes between two conditions (step 4). To identify deregulated MTs and their 
associated MiNs, a hypergeometric test is performed with a set of deregulated genes 
(step 5). 
 535	  
Minimal	  network	  significance	  based	  on	  gene	  set	  and	  reaction	  set	  (Step	  5)	  
The significance of the MiN based on the deregulated genes was calculated using the 
hypergeometric probability density function (P), 
𝑃 k,N,K,n = !! !!!!!!!! ,    (1) 
where k and K are the numbers of deregulated genes and the number of total genes in 540	  
a given MiN, respectively, and n and N are the total number of deregulated genes and 
the total number of genes of a metabolic network, respectively. In this context, the 
term “deregulated genes” is used for both up- or downregulated genes. 
 
A reaction can have three states: upregulated, downregulated, or unregulated. The 545	  
regulation of a reaction was determined based on its associated differentially 
expressed genes. According to this metric, a reaction was identified as upregulated or 
downregulated if the corresponding genes are only upregulated or only 
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downregulated, respectively. A reaction that is associated with a mixture of up- and 
downregulated genes is not characterized as regulated due to the inconsistency of 550	  
gene expression. Up- and downregulated MiNs, which could contain various 
combination of up- or downregulated reactions, were identified in Step 4 of MiNEA 
(Fig. 1) based on the total number of up- or downregulated reactions, respectively. As	  expected, up- and downregulated MiNs comprise markedly high numbers of up- and 
downregulated reactions, respectively. 555	  
 
The significance of a MiN based on upregulated or downregulated reactions was 
calculated using multivariate Fisher's hypergeometric distribution. This method has 
been previously used for the selection of tissue-specific elementary modes using gene 
expression data [6]. To identify significantly upregulated MiNs in a given set of 560	  
MiNs, we selected those MiNs that contained an elevated number of upregulated 
reactions and as few as possible downregulated ones, while for the identification of 
significantly downregulated MiNs, we selected MiNs with an elevated number of 
downregulated reactions and as few as possible upregulated ones.  	  565	  
Assume R and T are the total numbers of reactions in a GEM and a MiN, respectively, 
which can be decomposed as follows:  	   R  =  Rup  +  Rdown  +  RnoT  =  Tup  +  Tdown  +  Tno    (2) 	  570	  
Rup, Rdown, and Rno represent the number of upregulated, downregulated, and 
unregulated reactions in a GEM, respectively. In the context of a MiN, T is the total 
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number of reactions, and Tup, Tdown, and Tno are the number of upregulated, 
downregulated, and unregulated reactions, respectively.  
To consider a MiN as upregulated, we need to ensure that the pair (Tup, Tdown) in the 575	  
MiN of T reactions cannot arise by chance in the context of the whole network. To 
obtain a better upregulation by chance, the p value was computed using equation (3). 
Note that an equal or better outcome than the pair (Tup, Tdown) satisfies two conditions: 
(i) the number of downregulated reactions is smaller than or equal to Tdown, and (ii) 
the number of upregulated reactions is greater than or equal to Tup, whereas the 580	  
number of reactions in the MiN remains unchanged.  
 
p-­‐value  =   !up! !down! !no!!!!!   !!𝑖 + 𝑗 ≤ 𝑇!downj=!min !up,Ti=Tup     (3) 	  
We can compute the p value for downregulated reactions the same way as for the 585	  
upregulated reaction simply by changing up with down and down with up in the 
above equation. 
 
Deregulated	  percentage	  (DRP)	  
We calculated the deregulated percentage (DRP) for each MiN, which indicates the 590	  
percentage of up- or downregulated genes in a MiN. For example, if a given MiN 
comprises 20 genes, and 5 genes of the MiN are deregulated, the then DRP is equal to 
0.4. Since the active reactions in a MiN were classified as either up- or 
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downregulated, we calculated both upregulated percentage (UPR) and downregulated 
percentage (DnRP) for each MiN. 595	  
 
Alternative	  minimal	  network	  frequency	  (AMiNF)	  
To extend the degree of confidence of the results from MiNEA, we introduced the 
alternative minimal network frequency (AMiNF) metric that determines the 
significantly deregulated percentage of MiNs for a given MT. If all the alternative 600	  
MiNs for a MT are significantly deregulated, AMiNF takes the value 1. The AMiNF 
is 0 when none of the MiNs for a MT are significantly deregulated.  
 
MiNEA	  implementation	  
MiNEA was implemented using Matlab r2016a (The Mathworks, Natick, MA, USA), 605	  
and MILP problems were solved using CPLEX solver (ILOG, Sunnyvale, CA, USA). 
The MILP gaps for all problems were converged to less than 0.05% in less than 2,400 
s. We also plan to make the MiNEA algorithm available as a tool for distribution to 
the community.  
 610	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Conclusions	  	  
In contrast to graph-based methods (GBM) and pathway enrichment analysis (PEA), 
the methodology introduced here (MiNEA) expands the notion of pathway into in a 
set of mass balanced subnetworks that can be used to understand the carbon, energy, 
and redox flows from precursor metabolites to target metabolites and complex 615	  
metabolic tasks. One of the main advantages of MiNEA compared to PEA is that 
MiNEA attempts an enumeration of alternative minimal networks for each metabolic 
task (MT), which helps us understand and study the MT flexibility. Although a large 
number of alternative enumerations for a complex metabolic network can be time-
consuming, once the enumeration is completed, MiNEA applies a statistical analysis 620	  
that is fast and extracts additional information, such as pertaining to the deregulation 
of MTs or the deregulation in reaction hubs. As an example of the power of MiNEA, 
we identified deregulation in key metabolic network of the ceramide and hydrogen 
peroxide synthesis, of NASH in both humans and mice. We also identified similar 
deregulation in NASH for the cholesterol synthesis networks in humans and mice, and 625	  
we found opposite deregulation for the phosphatidylserine synthesis network between 
humans and mice. MiNEA is highly applicable for the study of context- or condition-
specific metabolism because using this one can identify synthesis networks for any 
given target metabolite and further can employ condition-specific transcriptomics, 
proteomics, and metabolomics data.  630	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Supplementary	  Tables	  635	  
Table S1. Differentially expressed genes for human and mouse expression data.  
Table S2. Upregulated reactions for human and mouse data. 
Table S3. Downregulated reactions for human and mouse data. 
Table S4. Minimal network enrichment analysis based on differentially expressed 
genes. Description of the table heading is illustrated in ‘Symbol’ sheet of the excel 640	  
file. Please see the Symbol sheet for the detail description for the tables: S5-S9.    
Table S5. Minimal network enrichment analysis based on upregulated reactions. 
Table S6. Minimal network enrichment analysis based on downregulated reactions. 
Table S7. Marked deregulated minimal networks selected based on Table S4.  
Table S8. Marked deregulated minimal networks selected based on Table S5.  645	  
Table S9. Marked deregulated minimal networks selected based on Table S6. 
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Comparison	  of	  human	  and	  mouse	  genome-­‐scale	  metabolic	  models	  
 
Mouse genome-scale metabolic model, iMM1415 [13] was reconstructed based on a 
human genome-scale metabolic model (Recon 1, [41]). Sigurdsson and collogues 680	  
found that the mammalian organism with the highest number of genes homologous to 
Recon 1 genes was the mouse (Mus musculus) (1,415 genes, 97%). We compared 
iMM1415 and Recon1 and found that the iMM1415 shares 98% of reactions with 
Recon1 and in the reaming 2 % reactions more than 1.5 % reactions were associated 
to the extracellular transport mechanism. This suggests that Recon1 and iMM1415 685	  
have very similar metabolism. 	  	  
Identification	  and	  analysis	  of	  deregulated	  genes	  and	  reactions	  in	  
human	  and	  mouse	  liver	  samples	  690	   	  
To understand the nonalcoholic fatty liver disease (NAFLD) and the difference of the 
disease in mouse and human we collected human expression data form the three 
diagnosis groups: normal (N), steatosis (S), and nonalcoholic steatohepatitis (NS), and 
mouse expression data form the control and DDC-supplement diet conditions for the 695	  
three mouse strains: AJ, B6 and PWD (Materials and Methods). These data were 
referred as human expression data and mouse expression data throughout this section. 
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Differential	  expressed	  genes	  in	  human	  liver	  samples	  700	  
To understand the NAFLD physiology we analyzed the differentially expressed genes 
(DEGs) in the human expression data. Out of the 1415 metabolic genes in iMM1415 
[13], we identified 29, 484 and 363 DEGs in S vs N, NS vs S, and NS vs N, 
respectively (Fig. S1 upper panel and Table S1). Only 29 DEGs between S vs N may 
explain that the metabolic state was very similar between normal and steatosis. The 705	  
total number of DEGs between NS vs N and NS vs S were much higher than S vs N, 
and thus suggest a more pronounced alteration of the metabolic state of nonalcoholic 
steatohepatitis compared to steatosis and normal. Furthermore, the number of 
downregulated genes is greater than the number of upregulated genes in exclusively 
NS vs N and NS vs S (Fig. S1), suggesting that, in human NASH, the perturbation 710	  
leading to the metabolic state that characterizes it, is reached by downregulated genes. 
	  
Differential	  expressed	  genes	  in	  mouse	  liver	  samples	  
We analyzed the mouse expression data for DEGs as described in the material and 
methods section. Out of the 1415 metabolic genes in iMM1415, the total number of 715	  
DEGs between control and DDC-supplemented diet was similar across all strains with 
247, 248 and 221 for AJ, B6 and PWD, respectively (Fig. S2 lower panel). Here, AJ 
and PWD are associated with NS vs N and S vs N, respectively (see materials and 
methods). Many up- and down-regulated genes were strain-specific. The number of 
up- and down-regulated strain-specific gene pairs for AJ, B6, and PWD were (48, 20), 720	  
(33, 29), and (39, 62), respectively (Fig. S1 lower panel and Table S1). The number of 
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up-regulated genes was greater than the number of down-regulated genes for the AJ 
strain, while for the PWD strain the opposite was true. Numbers of up- and down-
regulated genes were very similar for the B6 strain. Interestingly, the observed 
differences qualitatively correlate with the strains’ phenotypes: steatohepatitis 725	  
phenotypes were observed high, low, and unspecific for the AJ, B6, and PWD mouse 
strains, respectively [1]. 
 
We identified deregulated genes form the AJ under the DDC-supplemented diet vs 
PWD under DDC-supplemented diet and this is associated with NS vs S (see 730	  
materials and methods). For this comparison we identified 191 and 100 up- and down-
regulated genes, respectively (Table S1).  
 
Up-­‐	  and	  downregulated	  reactions	  in	  human	  and	  mouse	  
A reaction is marked as down regulated if genes associated to the reaction is down-735	  
regulated and if genes associated to the reaction is upregulated then the reaction is 
called as upregulated. If a reaction is associated to genes with mix-regulation (up- and 
down-regulation) then the reaction is not marked with up- or down-regulated. 
Regulations of reactions are computed for the human expression data and mouse 
expression data (Fig. S2).  740	  
Only for NS vs S, the number of down-regulated reactions was higher than the 
number of up-regulated reactions (Fig. S2 upper panel), and a similar trend was 
observed for the number of up- and down-regulated genes (Fig. S1 upper panel and 
Tables S2-S3). The number of reactions up- and down-regulated was similar for NS 
vs N, but the number of down-regulated genes was higher than the number of 745	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upregulated genes (Fig. S1 and S2 upper panels). For S vs N, the number of down-
regulated reactions was higher than the number of up-regulated reactions; however, 
the numbers of up- and down-regulated genes for these conditions were similar (Fig. 
S1 and S2 upper panels). This observation indicates that the reaction regulation (RR) 
is not always in agreement with the gene regulation, which results from the 750	  
dependency on the gene association set rather than a single gene. 	  
For the AJ and B6 mouse strains, we found that the number of upregulated reactions 
was higher than the number of downregulated reactions, whereas for the PWD mouse 
strain the inverse was observed (Fig. S2 lower panel). For AJ and PWD, the gene 755	  
regulation followed the same trend for reaction regulation, whereas for B6 the 
numbers of up- and down-regulated genes and reactions remained comparable (Fig. 
S1).  
To represents as the human NS vs S we compared mice that have shown high 
nonalcoholic steatohepatitis (NS) phenotypes (AJ mice fed with the DDC-760	  
supplemented diet) to mice that have shown high steatosis (S) phenotypes (PWD mice 
fed with DDC supplemented diet). For the NS vs S in mice (see materials and 
methods; AJ DDC vs PWD DDC) we identified 459 and 191 up- and down-regulated 
reactions, respectively (Table S 2-S3).  
 765	  
Supplementary	  Figures	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Figure S1. Venn diagram of differentially expressed genes of human and mouse liver 
samples. Upper and lower panels represent human and mouse, respectively.  
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 770	  
Figure S2. Venn diagram of up- and downregulated reactions of the iMM1415 in 
human and mouse liver samples. The reaction regulation metric was used to identify 
up- and downregulated reactions.	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